Ufenamate | m-entrepreneurship.com

Product Name :
Ufenamate

Search keywords :
Flufenamic acid

drugId :
null

Target Vo:
Cyclooxygenase-2

Target Vo Short Name :
COX-2

Moa_Name:
Cyclooxygenase-1 inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1982

Origin Company_Name :
Mitsubishi Tanabe Pharma

Active Company_Name :
Mylan EPD

Active Indication_Name:
Skin Diseases, Eczematous

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Pagibaximab supplier
PPAR gamma Rabbit pAb site
IL-8/CXCL8 Antibody: IL-8/CXCL8 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-IL-8/CXCL8 polyclonal antibody. IL-8/CXCL8 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rabbit, and predicted: pig, cow, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts